News
CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory ...
TipRanks on MSN17h
Gilead Sciences Advances Lung Cancer Treatment with New Clinical Study
Gilead Sciences (($CC:GILD.CUR)) announced an update on their ongoing clinical study. Gilead Sciences, in collaboration ...
Gilead shares slip after CVS refused to add its new HIV drug, Yeztugo, while its Kite unit struck a $350 million deal with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback